146 related articles for article (PubMed ID: 23432428)
1. Timing of office visits can be a powerful tool to improve adherence in the treatment of dermatologic conditions.
Heaton E; Levender MM; Feldman SR
J Dermatolog Treat; 2013 Apr; 24(2):82-8. PubMed ID: 23432428
[TBL] [Abstract][Full Text] [Related]
2. Adherence in dermatology.
Ahn CS; Culp L; Huang WW; Davis SA; Feldman SR
J Dermatolog Treat; 2017 Mar; 28(2):94-103. PubMed ID: 27180785
[TBL] [Abstract][Full Text] [Related]
3. Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies.
Shah A; Yentzer BA; Feldman SR
Cutis; 2013 Feb; 91(2):105-7. PubMed ID: 23513560
[TBL] [Abstract][Full Text] [Related]
4. Adherence to topical therapy increases around the time of office visits.
Feldman SR; Camacho FT; Krejci-Manwaring J; Carroll CL; Balkrishnan R
J Am Acad Dermatol; 2007 Jul; 57(1):81-3. PubMed ID: 17498841
[TBL] [Abstract][Full Text] [Related]
5. Pharmionics in dermatology: a review of topical medication adherence.
Lee IA; Maibach HI
Am J Clin Dermatol; 2006; 7(4):231-6. PubMed ID: 16901183
[TBL] [Abstract][Full Text] [Related]
6. Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998.
Hancox JG; Sheridan SC; Feldman SR; Fleischer AB
Int J Dermatol; 2004 Jan; 43(1):6-11. PubMed ID: 14693014
[TBL] [Abstract][Full Text] [Related]
7. Time Intervals Until the First Return Office Visit After New Medications.
Muddasani S; Heron CE; Fleischer AB; Feldman SR
J Drugs Dermatol; 2020 Dec; 19(12):1226-1230. PubMed ID: 33346517
[TBL] [Abstract][Full Text] [Related]
8. Dermatologic medication adherence.
Nolan BV; Feldman SR
Dermatol Clin; 2009 Apr; 27(2):113-20, v. PubMed ID: 19254654
[TBL] [Abstract][Full Text] [Related]
9. Improving the Effectiveness of Medication Review: Guidance from the Health Literacy Universal Precautions Toolkit.
Weiss BD; Brega AG; LeBlanc WG; Mabachi NM; Barnard J; Albright K; Cifuentes M; Brach C; West DR
J Am Board Fam Med; 2016; 29(1):18-23. PubMed ID: 26769873
[TBL] [Abstract][Full Text] [Related]
10. Assessing adherence to dermatology treatments: a review of self-report and electronic measures.
Greenlaw SM; Yentzer BA; O'Neill JL; Balkrishnan R; Feldman SR
Skin Res Technol; 2010 May; 16(2):253-8. PubMed ID: 20456106
[TBL] [Abstract][Full Text] [Related]
11. White coat adherence over the first year of therapy in pediatric epilepsy.
Modi AC; Ingerski LM; Rausch JR; Glauser TA; Drotar D
J Pediatr; 2012 Oct; 161(4):695-9.e1. PubMed ID: 22608905
[TBL] [Abstract][Full Text] [Related]
12. Underuse of early follow-up visits: a missed opportunity to improve patients' adherence.
Davis SA; Lin HC; Yu CH; Balkrishnan R; Feldman SR
J Drugs Dermatol; 2014 Jul; 13(7):833-6. PubMed ID: 25007367
[TBL] [Abstract][Full Text] [Related]
13. Adherence to topical treatment in psoriasis: a systematic literature review.
Devaux S; Castela A; Archier E; Gallini A; Joly P; Misery L; Aractingi S; Aubin F; Bachelez H; Cribier B; Jullien D; Le Maître M; Richard MA; Ortonne JP; Paul C
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():61-7. PubMed ID: 22512682
[TBL] [Abstract][Full Text] [Related]
14. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis.
Krejci-Manwaring J; Tusa MG; Carroll C; Camacho F; Kaur M; Carr D; Fleischer AB; Balkrishnan R; Feldman SR
J Am Acad Dermatol; 2007 Feb; 56(2):211-6. PubMed ID: 17224366
[TBL] [Abstract][Full Text] [Related]
15. Developing electronic monitor adapters for dermatologic medication containers: A methods paper.
Shah PM; Balogh EA; Van Gorkom AR; Brown PJ; Feldman SR
Skin Res Technol; 2022 Mar; 28(2):371-373. PubMed ID: 35246897
[No Abstract] [Full Text] [Related]
16. [The role of dermatologist in adherence to treatment].
Misery L
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S18-21. PubMed ID: 22305282
[TBL] [Abstract][Full Text] [Related]
17. Adherence in dermatology: a review of the last 20 years.
Hodari KT; Nanton JR; Carroll CL; Feldman SR; Balkrishnan R
J Dermatolog Treat; 2006; 17(3):136-42. PubMed ID: 16854752
[TBL] [Abstract][Full Text] [Related]
18. Non-adherence and measures to improve adherence in the topical treatment of psoriasis.
Zschocke I; Mrowietz U; Karakasili E; Reich K
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():4-9. PubMed ID: 24684738
[TBL] [Abstract][Full Text] [Related]
19. Assessment of "corticophobia" as an indicator of non-adherence to topical corticosteroids: A pilot study.
Mueller SM; Itin P; Vogt DR; Walter M; Lang U; Griffin LL; Euler S
J Dermatolog Treat; 2017 Mar; 28(2):104-111. PubMed ID: 27396480
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis treatment in the United States at the end of the 20th century.
Pearce DJ; Stealey KH; Balkrishnan R; Fleischer AB; Feldman SR
Int J Dermatol; 2006 Apr; 45(4):370-4. PubMed ID: 16650160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
